SAN CARLOS, Calif., Feb 09, 2006 (BUSINESS WIRE) -- Nektar Therapeutics (Nasdaq:NKTR) announced today that its corporate presentation will be webcast live from the BIO CEO and Investor Conference 2006 on Wednesday, February 15th, 2006, beginning at 2:00 p.m. Eastern Standard Time. The audio-only presentation may be accessed on Nektar's Investor Relations' page at www.nektar.com and will be available within 24 hours following the live presentation until March 2, 2006.
Nektar Therapeutics develops and enables high-value, differentiated therapeutics with its industry-leading drug delivery technologies, expertise and manufacturing capabilities. The world's top biotechnology and pharmaceutical companies are developing new and better therapeutics using Nektar's advanced technologies and know-how. Nektar also develops its own products by applying its drug delivery technologies and its expertise to existing medicines to enhance performance, such as improving efficacy, safety and compliance.
SOURCE: Nektar Therapeutics
Nektar Therapeutics Joyce Strand, 650-631-3138 Jennifer Ruddock, 650-631-4954
Copyright Business Wire 2006
News Provided by COMTEX